The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism
The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism is a paper indexed in ScholarIQ from OpenAlex.
How many citations does The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism have?
The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism has 152 citations in the OpenAlex counts ScholarIQ stores.
When was The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism published?
The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism has 2013 year in the ScholarIQ index.
What is the open-access status of The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism?
The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism has bronze oa status in the ScholarIQ index.
What is the DOI of The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism?
The DOI for The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism is on the source record.
What is the PMID of The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism?
The PMID for The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism is on the source record.
What is the OpenAlex record for The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism?
The OpenAlex for The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism is on the source record.